NovaBay Pharma (NBY) Misses Q3 EPS by 18c

November 10, 2016 4:27 PM EST

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.34), $0.18 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.02 million.

For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment